title: [Why review answer criteria in solid tumors ?].
authors.affiliation: AstraZeneca Clinical Development, Alderley Park, England.
authors.forename: Marcelo
authors.initials: M
authors.lastname: Marotti
mesh_terms: D018450:Disease Progression; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D009369:Neoplasms / Q000473:pathology*; D017410:Practice Guidelines as Topic